Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 910-356-7 | CAS number: -
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Acute Toxicity: oral
Administrative data
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- year of publication: 2013
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- guideline study without detailed documentation
- Remarks:
- no detailed information on observation periods, preparation of test item, and study design
Cross-reference
- Reason / purpose for cross-reference:
- reference to same study
Reference
- Endpoint:
- in vivo mammalian somatic cell study: cytogenicity / bone marrow chromosome aberration
- Type of information:
- experimental study
- Adequacy of study:
- supporting study
- Study period:
- year of publication: 2013
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- comparable to guideline study with acceptable restrictions
- Remarks:
- not fully conducted according to current guideline (older version), documentation lacking
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 475 (Mammalian Bone Marrow Chromosome Aberration Test)
- Version / remarks:
- 21 JUL 1997
- Deviations:
- no
- Principles of method if other than guideline:
- - Principle of test: bone marrow chromosome aberration assay
- Short description of test conditions: analysis was performed after rinsing the bone marrow cells (femur and tibia) from the rats as described by Adler (1984) Mutagenicity Testing: A Practical Approach Venitt S, Parry J (eds). IRL Press: Oxford; 273–306
- Parameters analysed / observed: determination of chromosome aberrations in metaphases, and mitotic index - GLP compliance:
- not specified
- Type of assay:
- other: chromosome aberration assay
- Specific details on test material used for the study:
- The study investigated test item in form of nano- and micron-sized particles. The mean size distribution of test item particles were 45 ± 17 nm for nano-particles and 2.74 ± 29 µm for micron-particles. Both particles acted comparable in the CA assay, therefore this record focuses on micron-sized particles only.
SOURCE OF TEST MATERIAL
- Source and lot/batch No.of test material: Sigma Chemical Co., St. Louis, USA
- Expiration date of the lot/batch: not specified
- Purity: ≥99%
STABILITY AND STORAGE CONDITIONS OF TEST MATERIAL
- Solubility and stability of the test substance in the solvent/vehicle: suspended in Milli Q water
TREATMENT OF TEST MATERIAL PRIOR TO TESTING
- Treatment of test material prior to testing: suspended various doses of test item in Milli Q water after sonication using a probe sonicator (UPH 100, Germany) for 10 min at 90% amplitude
OTHER SPECIFICS:
- specific surface area analysis was determined by using the Brunauer–Emmett–Teller technique = 7.95 (m2 /g) - Species:
- rat
- Strain:
- Wistar
- Remarks:
- albino
- Sex:
- female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: National Institute of Nutrition, Hyderabad, India
- Females (if applicable) nulliparous and non-pregnant: not specified
- Age at delivery: 6 to 8 weeks
- Weight at delivery: 80–120 g
- Fasting period before study: not specified
- Housing: in groups of five in polypropylene cages
- Diet: commercial pellet diet
- Water: ad libitum
- Acclimation period: one week
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 22 ± 3
- Humidity (%): 55–65
- Air changes (per hr): not specified
- Photoperiod (hrs dark / hrs light): 12 /12
IN-LIFE DATES: From: To: not specified - Route of administration:
- oral: gavage
- Vehicle:
- - Vehicle(s)/solvent(s) used: Milli Q water
- Details on exposure:
- - suspended in Milli Q water and then applied
- No information on vehicle volume for dose groups available, but control group received 5 ml/kg bw of Milli Q water. - Duration of treatment / exposure:
- single administration
- Frequency of treatment:
- single administration
- Post exposure period:
- 24 h
- Dose / conc.:
- 0 mg/kg bw/day
- Dose / conc.:
- 100 mg/kg bw/day
- Dose / conc.:
- 500 mg/kg bw/day
- Dose / conc.:
- 1 000 mg/kg bw/day
- No. of animals per sex per dose:
- 5 animals
- Control animals:
- yes, concurrent vehicle
- Positive control(s):
- cyclophosphamide
- Justification for choice of positive control(s): known mutagen
- Route of administration: intraperitoneally (i.p.)
- Doses / concentrations: 40 mg/kg bw in a 0.01 ml/kg bw volume - Tissues and cell types examined:
- Determination of chromosome aberrations in metaphases and mitotic index in cells.
- Details of tissue and slide preparation:
- CRITERIA FOR DOSE SELECTION: based on acute toxicity test
TREATMENT AND SAMPLING TIMES ( in addition to information in specific fields):
- analysis was performed at 18 and 24 h
DETAILS OF SLIDE PREPARATION:
- 3 slides for each animal were generated using the flame-dried technique
METHOD OF ANALYSIS:
- 500 well spread metaphases were selected to assess the presence of CAs, and 1000 or more cells were examined at both sampling times to determine the mitotic index (MI) - Evaluation criteria:
- CAs were identified using the established criteria of OECD guideline 475 (version 21 JUL 1997).
- Statistics:
- - results were expressed as means ± standard deviation (S.D.)
- statistically significant changes were analyzed using one-way ANOVA
- Multiple comparisons were performed using Dunnett’s test
- statistical significance for all tests was set at a p-value below 0.05
- for calculations Graph Pad Instat 3 software for Windows was used - Sex:
- female
- Genotoxicity:
- negative
- Toxicity:
- no effects
- Vehicle controls validity:
- valid
- Negative controls validity:
- not specified
- Positive controls validity:
- valid
- Additional information on results:
- Treatment with manganese dioxide did not show an increase (p > 0.05) in the total cytogenetic and structural (gaps, breaks, minute, acentric fragment and reciprocal translocation) changes, numerical (aneuploidy and polyploidy) CAs and percentage (%) of aberrant cells at all doses and treatment times. None of the treatment groups of test item showed significant differences in the mitotic index compared with control groups.
- Conclusions:
- The chromosome aberration assay of manganese dioxide did not show a statistically significant increase in total cytogenetic and structural changes, numerical CAs and percentage of aberrant cells at all doses and treatment times. Additionally, the mitotic index was not increased by manganese dioxide compared to control groups, indicating no bone marrow toxicity and genotoxicity.
- Executive summary:
In a bone marrow chromosome aberration assay comparable to OECD guideline 475, the test item was administered to female rats (5 per dose) orally by gavage at various doses (0, 100, 500, 1000 mg/kg bw), bone marrow cells extracted from the femurs and tibia were collected 18 and 24 h after treatment. For each animal three slides were prepared and assessed for the presence of CAs (500 metaphases investigated) and the mitotic index was determined after analysing more than 1000 cells. Both controls, negative vehicle and positive (cyclophosphamide), were valid. No statistically significant increase in CAs or the mitotic index compared to control groups was observed, resulting in the absence of genotoxicity and bone marrow toxicity.
Data source
Reference
- Reference Type:
- publication
- Title:
- Unnamed
- Year:
- 2 013
- Report date:
- 2013
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 420 (Acute Oral Toxicity - Fixed Dose Method)
- Version / remarks:
- 17 DEC 2001
- Deviations:
- no
- GLP compliance:
- not specified
- Remarks:
- no further information provided in the publication
- Test type:
- fixed dose procedure
- Limit test:
- yes
Test material
- Reference substance name:
- Manganese dioxide
- EC Number:
- 215-202-6
- EC Name:
- Manganese dioxide
- Cas Number:
- 1313-13-9
- Molecular formula:
- MnO2
- IUPAC Name:
- Manganese dioxide
- Test material form:
- solid
Constituent 1
- Specific details on test material used for the study:
- SOURCE OF TEST MATERIAL
- Source and lot/batch No.of test material: Sigma Chemical Co., St. Louis, USA
- Expiration date of the lot/batch: not specified
- Purity: ≥99%
STABILITY AND STORAGE CONDITIONS OF TEST MATERIAL
- Storage condition of test material: not specified
- Stability under test conditions: not specified
- Solubility and stability of the test substance in the solvent/vehicle: suspended in Milli Q water
- Reactivity of the test substance with the solvent/vehicle of the cell culture medium: not specified
TREATMENT OF TEST MATERIAL PRIOR TO TESTING
- Treatment of test material prior to testing: not specified, but a more detailed description was found for the genotoxicity test assay and was as followed: suspended in Milli Q water and properly ultrasonicated (UPH 100, Germany) for 10 min at 90% amplitude
- Preliminary purification step (if any): no
- Final dilution of a dissolved solid, stock liquid or gel: not specified
- Final preparation of a solid: no
FORM AS APPLIED IN THE TEST (if different from that of starting material): as a suspension
OTHER SPECIFICS:
- Size: mean= 2.74 ± 29 µm
- specific surface area analysis was determined by using the Brunauer–Emmett–Teller technique = 7.95 (m2 /g)
Test animals
- Species:
- rat
- Strain:
- Wistar
- Remarks:
- Albino
- Sex:
- female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: National Institute of Nutrition, Hyderabad, India
- Females (if applicable) nulliparous and non-pregnant: not specified
- Age at delivery: 6 to 8 weeks
- Weight at delivery: 80–120 g
- Fasting period before study: not specified
- Housing: in groups of five in polypropylene cages
- Diet: commercial pellet diet
- Water: ad libitum
- Acclimation period: one week
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 22 ± 3
- Humidity (%): 55–65
- Air changes (per hr): not specified
- Photoperiod (hrs dark / hrs light): 12 /12
Administration / exposure
- Route of administration:
- oral: gavage
- Vehicle:
- water
- Details on oral exposure:
- - suspended in Milli Q water and then applied
- No information on vehicle volume for dose groups, but control group received 5 ml/kg bw of Milli Q water. - Doses:
- fixed dose: 2000 mg/kg bw
- No. of animals per sex per dose:
- 5 female rats
- Control animals:
- yes
- Details on study design:
- - Duration of observation period following administration: 14 days
- Frequency of observations and weighing: not specified, as shown in a graphic for food intake: 1, 3, 7, 10, and 14 d, for body weight: 0, 3, 7, 10, and 14 d after oral administration
- Necropsy of survivors performed: yes
- Other examinations performed: clinical signs: yes
body weight: yes
organ weights: yes
histopathology: yes - Statistics:
- The results were expressed as means ± standard deviation (S.D.). Statistically significant changes were analyzed using one-way ANOVA. Multiple comparisons were performed using Dunnett’s test and statistical significance for all tests was set at p < 0.05. All calculations were performed using Graph Pad Instat 3 software for Windows.
Results and discussion
- Preliminary study:
- In an observational study, no mortality or toxic symptoms were seen at any dose levels (5, 50, 300, and 2000 mg/kg bw) administered.
Effect levels
- Key result
- Sex:
- female
- Dose descriptor:
- LD50
- Effect level:
- > 2 000 mg/kg bw
- Based on:
- test mat.
- Mortality:
- There was no case of mortality observed.
- Clinical signs:
- No adverse signs or symptoms were observed.
- Body weight:
- No significant changes were observed in food consumption or body weight.
- Gross pathology:
- The test item did not induce treatment-related effects.
- Other findings:
- - Organ weights: relative weights of liver, kidney, brain, heart and spleen did not significantly change.
- Histopathology: At the highest dose (2000 mg/kg bw) spleen, brain, and liver tissue of rats revealed lesions: spleen showed congestion, brain displayed inflammation, and the liver depicted a dilated central vein. However, rats exposed to 5, 50, 300 and 2000 mg/kg bw of test item showed normal architecture of the spleen, brain, liver, heart and kidney tissues.
Applicant's summary and conclusion
- Interpretation of results:
- GHS criteria not met
- Conclusions:
- Single oral administration of the limit dose of 2000 mg test item per kg bw did not cause lethality in 5 female albino Wistar rats during the 14 day observation period, resulting in a LD50 > 2000 mg/kg bw.
- Executive summary:
To evaluate the acute toxicity after a single oral administration according to OECD Guideline 420 (acute oral toxicity-fixed dose method), the test item was administered to female albino Wistar rats (5 animals/group) at doses of 0 and 2000 mg/kg bw. Mortality, clinical signs, body weight changes, food consumption, gross findings and relative organ weights (liver, kidney, brain, heart, and spleen) were screened for 14 days following the single dose. No treatment-related effects on mortality, clinical signs, body weight changes, food consumption, gross findings, and relative organ weights in Wistar rats treated with a single oral dose of test item were observed. Therefore, the LD50 value of the test item was considered to be over 2000 mg/kg bw for female rats.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.